Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04052971
Title To Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of ABN401 in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer Harboring c-MET Dysregulation
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Abion Inc
Indications

prostate cancer

melanoma

carcinoma

lung non-small cell carcinoma

breast cancer

sarcoma

Therapies

ABN401

Age Groups: adult | senior
Covered Countries


No variant requirements are available.